Psoriasis is a chronic systemic inflammatory disease. Due to systemic inflammation, it is associated with many comorbidities. Among them, cardiovascular diseases represent the most common causes of morbidity and mortality in this population. Therefore, physicians treating patients with psoriasis should keep in mind that, as important as the treatment of psoriasis, awareness of cardiovascular risk deserves additional attention. Thus, in parallel with psoriasis treatment, a cardiovascular risk assessment must also be performed and addressed accordingly. In addition to encouraging non-pharmacologic strategies for a healthy lifestyle, physicians should be familiar with different pharmacologic options that can target psoriasis and reduce cardiovascular risk. In the present article, we present the pathophysiological mechanisms of the psoriasis and cardiometabolic interplay, our view on the interaction of psoriasis and cardiovascular disease, review the atherosclerotic effect of therapeutic options used in psoriasis, and vice versa, i.e., what the effect of medications used in the prevention of atherosclerosis could be on psoriasis.
Background: Existing data on contact sensitisation prevalence among children and adolescents is limited, especially regarding comparisons of specific allergens over extended timeframes. The objective of this study was to identify the most common allergens and to evaluate shifts in contact sensitisation trends. Methods: We retrospectively evaluated patch test data of 1052 children and adolescents referred to a single tertiary medical centre. The analysis covered three periods: 2000–2004, 2010–2014, and 2020–2024. All patients were tested with the time‐recommended baseline series of allergens. Results: A significant decrease was reported for nickel prevalence, dropping from 12.6% to 4.0%. Although tested only in the latest period, textile dye mix (4.7%) and methylisothiazolinone (3.2%) emerged as important allergens. Children with atopic dermatitis (AD) showed a higher prevalence of contact sensitisation (27.7% vs. 22.7%). In contrast, among adolescents, rates were lower in those with AD (20.0% vs. 30.7%). Conclusions: Our findings demonstrate a marked decline in nickel sensitisation, while dyes and preservatives are gaining importance. The clinical relevance of specific allergens is evolving in response to regulations and market trends. Continuous surveillance of contact sensitisation is also essential in the pediatric population to ensure that patch testing strategies and preventive measures remain current, targeted and effective.
30 December 2019 in Acta Dermatovenerologica Alpina Pannonica et Adriatica
Enterobiasis is the most common parasite infestation in children; it is often asymptomatic and may rarely be a cause of skin eruption. We present the case of a 7-year-old boy with sudden onset of pruritic erythemato-squamous confluent papules and plaques on UV-exposed skin, caused by proven enterobiasis. To our understanding, this is the first case of photodermatosis-like dermatitis caused by enterobiasis reported in the literature.
Background: Topical corticosteroid phobia (CSP) is a significant barrier to the effective treatment of atopic dermatitis (AD). This is the first study to evaluate the CSP prevalence among parents of children with AD in Slovenia and to identify contributing factors. Methods: We conducted a cross‐sectional study between March 2021 and December 2023. Parents of children with dermatologist‐confirmed AD, aged 3 months to 18 years, completed the validated TOPICOP questionnaire, supplemental questions and the (F)DLQI questionnaire. The SCORAD index was used to assess the severity of their children’s AD disease. Statistical analyses included the Shapiro–Wilk test, two‐tailed independent t ‐test, ANOVA, followed by Tukey post hoc testing and the Pearson correlation coefficient. Results: Among 117 parents (81.2% mothers), the mean TOPICOP score was 48.2% (SD 15.1). Fear was the highest‐scoring TOPICOP domain (53.7%). CSP was significantly higher in parents of children with more severe AD based on SCORAD ( p = 0.033) and in families with higher (F)DLQI scores ( r = 0.311, p = 0.002). Notably, our results suggest that parents of children in single‐parent households had significantly higher CSP ( p = 0.035), a novel finding that warrants cautious interpretation due to the small subgroup size. Information obtained online about the potential dangers of topical corticosteroids (TCS) correlated with higher CSP ( p < 0.001). Conclusion: CSP is prevalent among Slovenian parents of children with AD and is particularly pronounced in cases of more severe disease and single‐parent households, a novel and previously undescribed finding. Given that CSP is often influenced by nonmedical information sources, structured education and support by all healthcare providers is essential.